Pharmaron Beijing Co.,Ltd.’s Net Profit Rose 47.8% in First Quarter of 2023

Pharmaron Beijing Co.,Ltd. (康龙化成(北京)新药技术股份有限公司) (300759.SZ) reported a net profit of 350.1 million yuan in the first quarter of 2023, up 47.8% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 29.5% year-on-year.

At the end of the reporting period, it had 21 billion yuan in total assets and 9.8 billion yuan in total liabilities, with a liability-to-asset ratio of 46.4%.